Photo from Pashtoon Kasi/LinkedIn
Mar 26, 2024, 15:02
Pashtoon Kasi: With BOT/BAL in our NEST trial, we are seeing ctDNA decline and CLEAR within days to 2-4 weeks
Pashtoon Kasi, Director for Colorectal Cancer Research at Weill Cornell Medicine shared on LinkedIn:
“We grossly underestimate how quickly immunotherapy can work. Especially with BOT/BAL (botensilimab) in our NEST trial, we are seeing ctDNA decline and CLEAR within days to 2-4 weeks. Unprecedented!
March is Colorectal Cancer Awareness Month.”
Proceed to the article.
Source: Pashtoon Kasi/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 14:55
Nov 13, 2024, 14:47
Nov 13, 2024, 14:43
Nov 13, 2024, 14:37
Nov 13, 2024, 14:05
Nov 13, 2024, 12:13
Nov 13, 2024, 11:52
Nov 13, 2024, 11:48